Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort.
STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression.
Central Nervous System Infections With Immunomodulatory Therapies.
Genetic predictors of relapse rate in pediatric MS.
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
Subgroup analysis in MS trials.
The risks for falls and fractures in multiple sclerosis.
Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer's Disease, Huntington's Disease and Multiple Sclerosis.
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients.
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy.
Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.
Current status of chemokines in the adult CNS.
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.
Oligodendroglia and neurotrophic factors in neurodegeneration.
A nexus between lipids and multiple sclerosis?
cFLIP is critical for oligodendrocyte protection from inflammation.
Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.

Pages